Patents Assigned to Morton Grove Pharmaceuticals, Inc.
  • Stable warfarin sodium liquid formulation and method of making same
    Patent number: 7259185
    Abstract: A stable liquid composition comprising warfarin sodium, glycerin, an alcohol such as ethanol, and a pH buffer such as a phosphate buffer providing a pH above 7 is provided. The stability of the composition is characterized by the amount of warfarin sodium in the composition degraded after 1 month at room temperature, which is 5% or less. A method for preparing the composition and a method for providing an anti-coagulant therapy are also disclosed.
    Type: Grant
    Filed: June 14, 2006
    Date of Patent: August 21, 2007
    Assignee: Morton Grove Pharmaceuticals, Inc.
    Inventors: Meagan Erica Weldele, David Delmarre, Danchen Gao, Mahmoud Assad El-Khateeb, Carlos-Julian Sison Centeno, Shitalkumar Ratnakar Pathak
  • Spontaneous emulsions containing cyclosporine
    Patent number: 6960563
    Abstract: A pharmaceutical composition contains cyclosporine as the active ingredient. More specifically, the composition is an orally administered pharmaceutical formulation in the form of a spontaneous emulsion comprising cyclosporine, ethanol ethyl oleate and polyoxyethylene glycerol trioleate. A method for preparing an orally administered pharmaceutical composition involves first dissolving cyclosporine in ethanol. Polyoxyethylene glycerol trioleate and an oil component are then added, mixed and diluted in an aqueous media to form a spontaneous emulsion.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: November 1, 2005
    Assignee: Morton Grove Pharmaceuticals, Inc.
    Inventors: Kamel F. Egbaria, Michael J. Groves